MedTech
MedTech market is expanding: What does this mean for modern clinical trials?
The MedTech market is not just growing, it is transforming.
Valued at over $650 billion globally in 2026, the industry is projected to surpass $800 billion within the next decade, driven by innovation in devices, digital health, and data-driven care.¹²
As demand for better diagnostics, personalized treatment, and remote monitoring increases, the role of MedTech continues to expand across the entire healthcare ecosystem.
For clinical teams, this growth is more than a market trend, it is changing how studies are designed, executed, and scaled.
Growth is being driven by technology, not just demand
MedTech has always been innovation-led, but the pace has changed significantly in recent years.
Several key drivers are affecting this expansion:
- Digital health adoption, including wearables and connected devices
- Artificial intelligence, improving diagnostics and decision-making
- Remote monitoring, enabling care outside traditional settings
- Minimally invasive and robotic technologies, advancing treatment options
These are redefining what MedTech products look like and how they are evaluated.
For example, Software as a Medical Device (SaMD) is one of the fastest-growing segments in the industry, with projected growth rates exceeding 30% annually in some markets.³ This signals a clear shift toward software-driven, continuously evolving medical solutions.
The shift toward continuous, real-world data
Traditional studies relied heavily on structured, site-based data collection. Today, MedTech solutions, especially connected devices and software, produce:
- Continuous patient data
- Real-world usage insights
- Longitudinal performance data beyond the clinical setting
This change aligns with a broader industry movement toward real-world evidence and outcome-based care, where regulators and stakeholders increasingly expect proof of performance outside controlled environments.
At the same time, decentralized clinical trials are expanding rapidly, projected to grow at over 13% annually through 2034, enabled by digital tools such as wearables and ePRO systems.⁴
For MedTech, this means trials are no longer limited to sites, they extend into patients’ daily lives.
From products to ecosystems
Another defining trend in the MedTech market is the move from standalone products to connected ecosystems. Devices are no longer evaluated in isolation. They are part of broader solutions that combine:
- Hardware
- Software
- Data platforms
- Clinical workflows
Instead of focusing only on product performance, organizations are building integrated offerings that include monitoring, analytics, and long-term patient engagement. Industry insights suggest that future growth will increasingly come from these data-enabled services and connected care models, rather than devices alone.⁵
What this means for MedTech teams
As the MedTech market grows and evolves, clinical teams are operating in a different environment. They are no longer just evaluating a device or a piece of software. They are generating evidence for:
- Connected systems
- Continuous data flows
- Hybrid care models
- Products that evolve over time
This requires:
- Flexible study designs
- Scalable data infrastructure
- Strong alignment between clinical, regulatory, and technical teams
In short, the expansion of the MedTech market is directly affecting how trials are conducted.
Conclusion
The MedTech market is expanding in size, but more importantly, in scope. As devices become smarter, software becomes central, and data becomes continuous; the expectations placed on clinical trials are changing.
Understanding this change is critical. Because in a rapidly evolving market, the ability to generate high-quality clinical evidence is not just a regulatory requirement; it is a competitive advantage.
References
Statista. (2026). Medical Technology market revenue worldwide. Accessed May 20, 2026. https://www.statista.com/outlook/hmo/medical-technology/worldwide
Business Research Insights. (2026). MedTech Market Size and Forecast 2035. Accessed May 20, 2026. https://www.businessresearchinsights.com/market-reports/med-tech-medical-technology-market-117917
Market Growth Reports. (2025). Software as a Medical Device (SaMD) Market Growth. Accessed May 20, 2026. https://www.marketgrowthreports.com/market-reports/software-as-a-medical-device-samd-market-100075
Global Market Insights. (2025). Decentralized Clinical Trials Market Forecast. Accessed May 20, 2026. https://www.gminsights.com/industry-analysis/decentralized-clinical-trials-market
PwC. (2025). Next in MedTech: Industry Insights. Accessed May 20, 2026. https://www.pwc.com/us/en/industries/health-industries/medical-technology/medtech-industry-insights.html
May 26, 2026
Why a unified platform is essential for modern MedTech trials
Blogs
April 28, 2026
Top EDC software solutions for clinical trial teams
Blogs
April 14, 2026
Solving MedTech trial complexity with the right technology partner
Blogs